Literature DB >> 30798277

Unusual KRAS missense mutation (p.E63K) in patient with juvenile pilocytic astrocytoma of the tectum.

Lianne Q Chau1, Michael L Levy2, John Ross Crawford3.   

Abstract

Entities:  

Keywords:  CNS cancer; paediatric oncology

Mesh：

Substances：

Year:  2019        PMID： 30798277      PMCID： PMC6441274          DOI： 10.1136/bcr-2018-228128

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.

Authors:  Huriye Cin; Claus Meyer; Ricarda Herr; Wibke G Janzarik; Sally Lambert; David T W Jones; Karine Jacob; Axel Benner; Hendrik Witt; Marc Remke; Sebastian Bender; Fabian Falkenstein; Ton Nu Van Anh; Heike Olbrich; Andreas von Deimling; Arnulf Pekrun; Andreas E Kulozik; Astrid Gnekow; Wolfram Scheurlen; Olaf Witt; Heymut Omran; Nada Jabado; V Peter Collins; Tilman Brummer; Rolf Marschalek; Peter Lichter; Andrey Korshunov; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-03-20       Impact factor: 17.088

Review 2.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

Review 3.  Pilocytic astrocytoma: pathology, molecular mechanisms and markers.

Authors:  V Peter Collins; David T W Jones; Caterina Giannini
Journal:  Acta Neuropathol       Date:  2015-03-20       Impact factor: 17.088
  3 in total
  2 in total

1.  Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.

Authors:  Yasuhide Makino; Yoshiki Arakawa; Ema Yoshioka; Tomoko Shofuda; Sachiko Minamiguchi; Takeshi Kawauchi; Masahiro Tanji; Daisuke Kanematsu; Masahiro Nonaka; Yoshiko Okita; Yoshinori Kodama; Masayuki Mano; Takanori Hirose; Yohei Mineharu; Susumu Miyamoto; Yonehiro Kanemura
Journal:  BMC Cancer       Date:  2021-09-15       Impact factor: 4.638

2.  Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.

Authors:  Jason Chiang; Xiaoyu Li; Anthony P Y Liu; Ibrahim Qaddoumi; Sahaja Acharya; David W Ellison
Journal:  Acta Neuropathol       Date:  2019-12-10       Impact factor: 17.088
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.